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Objective.– Urinary symptoms are very frequent in MS [1]. The high prevalence
of women in MS and the age demographic affected in MS suggests that SUI could
be common.
Methods.– Three hundred and forty-three MS women with urinary symptoms
questionnaire (USP), quality of life questionnaire (Qualiveen), Expanded Dis-
ability Status Scale (EDSS), and urodynamic exploration were selected.
Results.– The mean age was 48.8 years old (20–77); mean EDSS was 5.45.
The mean number of vaginal deliveries was 1.4. Hundred and fifty-six women
(45.5%) reported SUI (USP SUI > 2/9). Three hundred and twelve women (91%)
had overactive bladder (OAB) (USP OAB > 2/21). Ninety-seven percent of
women had an associated SUI and OAB. The average uretral closure pressure
measurement (MUCP) was 69 cmH20. Women with SUI had significantly lower
MUCP and higher age (P < 0.05). No correlation was found between SUI and
detrusor overactivity (DO) in urodynamics (P > 0.05), the number of vaginal
deliveries (P > 0.05) or EDSS score (P > 0.05).
Discussion.– The prevalence of SUI in MS women is 45.5%, independent of the
degree of disability. SUI is correlated with the age and the MUCP. Our results
do not support the SUI prevalence data described [2].
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Multiple sclerosis (MS) is a chronic immune mediated disease affecting the cen-
tral nervous system, and characterized by demyelination and axonal damage.
The estimated prevalence of MS is approximately 2.5 million cases worldwide
and the disease is the first most common cause of neurological disability in
young adults. If untreated, MS typically leads to substantial accumulation of
both physical and cognitive disability over time. For that reason, early use of
disease-modifying therapies is required. These treatments should reduce relapse
rate, limit the onset of new demyelinating lesions and postpone the develop-
ment of long-term disability. Currently first-line-approved immunomodulator
therapies for MS reduce disease activity and the accumulation of disability in
relapsing remitting MS. Although these first-line treatments have shown excel-
lent safety profiles, their effects are modest and all have to be given by injection.
Immunosuppressive drugs are also approved for treatment of MS as second-
line therapy, demonstrating greater efficacy but also many severe safety adverse
events. Thus, there remains an unmet need for the development of more effective
and well-tolerated oral therapies for the treatment of MS. Based on results of
large randomized controlled trials, a number of oral medications have already
been or will be approved.
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Objective.– This study aimed to test the hypothesis that clinical improvement
following physical rehabilitation is associated with regional brain plasticity in
disabled patients suffering from multiple sclerosis (MS).
Results.– Fourteen MS patients with a lower limb motor deficit underwent a
one-month standardized physical rehabilitation protocol. Clinical examination,
resting-state functional MRI (rs-fMRI) and structural MRI were performed at
inclusion, just after rehabilitation, and three months after the end of rehabilita-
tion. Topology of brain networks was analysed based on graph-theory method
applied to rs-fMRI data. Morphological variations in grey matter (GM) were
determined using longitudinal Voxel-Based Morphometry method applied to
3D T1-weighted images.
Discussion.– Graph-theory analysis evidenced after rehabilitation an increase
of the local connectivity in the default mode network (DMN) and the central
executive network (CEN). The amount of connectivity changes depicted in the
DMN and the CEN was correlated to the clinical improvement. Structural MRI
evidenced a significant increase in GM density in the left fronto-orbital cortex
immediately after rehabilitation correlating with clinical improvement. After the
end of rehabilitation, structural and functional brain reorganization progressively
disappeared and clinical performances returned to baseline level.
Conclusion.– The study evidences that the transient clinical improvement fol-
lowing physical rehabilitation in MS patients is associated with reversible
plasticity mechanisms.
http://dx.doi.org/10.1016/j.rehab.2014.03.1103
CO28-003-e
Physical training and muscle strengthening
in multiple sclerosis
P. Gallien ∗, B. Nicolas , A. Durufle , S. Robineau ,
S. Petrilli , K. Autret , J. Houedakor , C. Le Meur
Pôle Saint-Helier, Saint-Grégoire, France
∗Corresponding author.
Keywords: Multiple sclerosis; Physical training; Muscle strengthening
During a long time physical activity was not recommended for patients with
multiple sclerosis for fear of worsening neurological symptoms. The practice
of physical activity depends on the possibilities of adaptation to stress, and
disability. For high EDSS scores cardiovascular abnormalities adaptation and
impaired respiratory function may be observed with perturbations of exercise
testing as consequences. Muscle deficits, coordination disorders can also be an
obstacle to physical activity increasing the deconditioning consecutive to the
restriction of physical activity.
Various studies have shown the benefit of physical training with an improvement
in VO2 max, gait parameters and fatigue. A real impact on quality of life is also
observed. Regular physical activity is necessary for maintaining the benefit of
rehabilitation training programs.
The combination of muscle strengthening potentiates the benefit obtained. Sports
should be recommended depending on the clinical feature and adapted to the
fatigue in his practice and this al all along the disease course.
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Multiple sclerosis is an inflammatory disease of central nervous system with
both scattered and evolutive lesions. It is characterized by the appearance at a
time variable in the development of disorders of balance and gait moving towards
progressive disability.
In MS, balance impairment is responsible for falls that occur at different
stages of the disease. Imbalance and falls are related not only to impairment of
motor control but also of the proprioception, the cerebellar function and vision.
Spasticity and cognitive troubles have also been related to increased risk of falls.
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The assessment of balance in multiple sclerosis can be done in practice with
clinical tests. It may be supplemented by instrumental tests that help to better
understand the origin and evolution under treatment.
The aim of rehabilitation in patients with multiple sclerosis is determined
by the level of impairment. In less affected patients, an improvement can be
expected in balance. Specific rehabilitation program seems to be more accurate
than non-specific training programs. Cognitive and motor impairments are the
most limiting factors in the most advanced stages of the diseases.
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Objective.– To define the place of patient therapeutic education (PTE) into
multiple sclerosis management.
Methods.– Systematic literature review in PubMed and Cochrane Library
databases from 1966 to 2010 with the keywords “multiple sclerosis”, “self-
care”, “self-management”. Clinical trials and studies in English, French, and
literature reviews and practice guidelines are analyzed.
Results.– Several studies concern general health (7 studies), fatigue management
(12 studies) or pain (7 studies). There are less studies concerning prevention of
falls (1 study), cognitive disorders, mood and behavior (3 studies) and genito-
sexual disorders (1 study).
Conclusion.– TPE is part of the management of MS, particularly through the
practice of physical activity and fatigue management. It is also essential to
validate information content and to develop educational tools for MS patients.
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Objective.– To characterize walking fatigability in Multiple sclerosis (MS)
patients.
Methods.– Seventy-six patients (51.1 ± 11 yo; median EDSS = 5, min = 4–max =
6.5) performed the Timed 25-Foot Walk Test (T25FWT), the 2-minute Walk Test
(2MWT) and five successive trials at maximum walking speed on a GAITRITE
electronic walkway (8 m).
Results.– In the low EDSS group (4–5; n = 46), walking fatigability was only
observed for the 2MWT (–0.12 m.s−1 that is–11% between the first and last
quarter of the test). In the high EDSS group, absolute decrease in walking speed
was not different compared to the low EDSS group (–0.12 m.s−1), but fatiga-
bility was higher relatively to initial walking speed (–19%; P = 0.018). Walking
distance for the 2MWT was significantly lower in the high EDSS group (72
vs 117 m; P < 0.001). In both groups, walking fatigability was mainly due to a
decrease in walking cadence.
Discussion.– Absolute gait fatigability seems to be independent of functional
status in MS patients, at least for short to middle walking distances. This empha-
sizes the role of walking speed and cadence training in rehabilitation programs
in MS patients.
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Objective.– To assess efficacy of fampridine on walking parameters, hand func-
tion, fatigue and quality of life (QoL) in patients with multiple sclerosis (MS).
Methods.– Hundred and eleven consecutive patients eligible for fampridine treat-
ment were evaluated before and after 2 weeks (W2) of treatment, and finally after
3 months (M3) for responders. Response criteria were defined as an improve-
ment of at least 15% in the Timed-25-Foot-Walk (T25FW), the 2-Minute Walk
Test (2MWT) or the MS Walking Scale (MSWS-12). Moreover, we performed
an analysis of spatio-temporal gait parameters (GAITRITE), and assessments
of fatigue (Visual Analog Scale (VAS), hand function (Nine Hole Peg Test) and
QoL (SF-12).
Results.– Eighty-five patients (76.6%) were found to be responders, improving
T25FW by 33.6% at W2 (vs 4.8% in non-responders) and 31.8% at M3, 2MWT
by 38.4% (vs8.5%) and 35.6% and MSWS by 18%. Furthermore, responders
showed an amelioration of fatigue severity (P < 0.01), hand function (P < 0.05)
and QoL (P < 0.001).
Discussion.– In responders, fampridine improves walking, but also other general
symptoms and QoL. It could be of interest in the rehabilitation of MS patients.
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Background.– Fatigue and depression are the most common problems in multiple
sclerosis (MS) and strong associations have been reported between them in
numerous studies. The purpose of the study was to investigate the seasonal
variation of fatigue and depression during every season of the year in a Greek
sample of MS patients.
Methods.– Forty-five patients with MS participated in the study. Measurements
of fatigue and depression were made with fatigue severity scale (FSS) and Beck
depression Inventory (BDI) respectively. The measurements were conducted
every three months (November, February, May and August) on the last day
of each month during a year. Mean value (M) of fatigue for MS patients was
(M = 4.20 SE = 0.22.).
Results.– No significant fluctuation of fatigue and depression were observed
in patients with MS. This finding confirms previous reports of fatigue and
depression stability on 6-month basis.
